6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18442857 | BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND TUMOR ANTIGENS, AND USES THEREOF | LU, CHENG | 1642 | Final Rejection | Feb 15, 2024 |
| 18320599 | TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | May 19, 2023 |
| 18178783 | COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF | BUNNER, BRIDGET E | 1647 | Non-Final OA | Mar 06, 2023 |
| 18164952 | Covalent Diabodies and Uses Thereof | DUFFY, BRADLEY | 1643 | Non-Final OA | Feb 06, 2023 |
| 17787793 | Therapy for the Treatment of Cancer | LUNDE, GRACE HENRY | 1641 | Final Rejection | Jun 21, 2022 |
| 17570530 | Covalent Diabodies and Uses Thereof | DUFFY, BRADLEY | 1643 | Non-Final OA | Jan 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial